Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed COO
|
|
MyoKardia, Inc. (MYOK)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/19/2020 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $11.55, valued at
$254.1k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| McDowell Robert Scott (Chief Scientific Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 36,616 shares
@ $0
Disposed/sold 87,074 options to buy
@ $0.1838, valued at
$16k
Disposed/sold 40,816 options to buy
@ $0.3308, valued at
$13.5k
Disposed/sold 36,735 options to buy
@ $1.5068, valued at
$55.4k
Disposed/sold 27,211 options to buy
@ $9.08, valued at
$247.1k
Disposed/sold 79,850 options to buy
@ $12.25, valued at
$978.2k
Disposed/sold 20,000 options to buy
@ $13.9, valued at
$278k
Disposed/sold 46,000 options to buy
@ $52, valued at
$2.4M
Disposed/sold 57,400 options to buy
@ $40.11, valued at
$2.3M
Disposed/sold 38,818 options to buy
@ $70.4, valued at
$2.7M
|
|
| 11/19/2020 |
4
| Harris Taylor C. (CFO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 42,559 shares
@ $0
Disposed/sold 100,000 options to buy
@ $48.5, valued at
$4.9M
Disposed/sold 49,400 options to buy
@ $40.11, valued at
$2M
Disposed/sold 46,060 options to buy
@ $70.4, valued at
$3.2M
|
|
| 11/19/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $7.4, valued at
$162.8k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Fairey William (EVP, Chief Commercial Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 42,199 shares
@ $0
Disposed/sold 69,500 options to buy
@ $40.99, valued at
$2.8M
Disposed/sold 39,022 options to buy
@ $70.4, valued at
$2.7M
|
|
| 11/19/2020 |
4
| Bauer Jake (Chief Business Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 90,209 shares
@ $0
Disposed/sold 16,530 options to buy
@ $1.5068, valued at
$24.9k
Disposed/sold 8,748 options to buy
@ $9.08, valued at
$79.4k
Disposed/sold 35,150 options to buy
@ $12.25, valued at
$430.6k
Disposed/sold 57,400 options to buy
@ $40.11, valued at
$2.3M
Disposed/sold 34,000 options to buy
@ $52, valued at
$1.8M
Disposed/sold 45,193 options to buy
@ $70.4, valued at
$3.2M
|
|
| 11/19/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 29,508 shares
@ $0
Disposed/sold 21,800 options to buy
@ $10, valued at
$218k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $14.35, valued at
$315.7k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| CRANSTON MARY B (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 141,405 shares
@ $0
Unknown transaction of 129,407 shares
@ $0
Unknown transaction of 300,000 shares
@ $0
Unknown transaction of 7,000 shares
@ $0
Unknown transaction of 10,000 shares
@ $0
Unknown transaction of 53,087 shares
@ $0
Disposed/sold 149,517 options to buy
@ $1.5068, valued at
$225.3k
Disposed/sold 72,562 options to buy
@ $9.08, valued at
$658.9k
Disposed/sold 303,500 options to buy
@ $12.25, valued at
$3.7M
Disposed/sold 184,100 options to buy
@ $52, valued at
$9.6M
Disposed/sold 236,500 options to buy
@ $40.11, valued at
$9.5M
|
|
| 11/19/2020 |
4
| YARNO WENDY L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 5,508 shares
@ $0
Disposed/sold 22,000 options to buy
@ $14.35, valued at
$315.7k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 11/19/2020 |
4
| Waynick Denelle J (Chief Legal Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 25,000 shares
@ $0
Disposed/sold 80,000 options to buy
@ $93.84, valued at
$7.5M
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| Popovits Kimberly J (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| Meeker David P (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| PERRY MARK L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| YARNO WENDY L (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| CRANSTON MARY B (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/04/2020 |
4
| GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Sold 600 shares
@ $100.595, valued at
$60.4k
Sold 800 shares
@ $101.7225, valued at
$81.4k
Sold 1,396 shares
@ $102.7804, valued at
$143.5k
Sold 1,885 shares
@ $103.7716, valued at
$195.6k
Sold 319 shares
@ $104.6446, valued at
$33.4k
|
|
| 06/04/2020 |
4
| Bauer Jake (Chief Business Officer) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Granted 293 shares
@ $50.4135, valued at
$14.8k
|
|
| 05/20/2020 |
4
| GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Sold 10,000 shares
@ $125, valued at
$1.3M
|
|
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2020 |
4
| GIANAKAKOS ANASTASIOS (President and CEO) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Sold 1,000 shares
@ $55, valued at
$55k
Gifted 200,865 shares
@ $0
Gifted 200,865 shares
@ $0
Gifted 122,661 shares
@ $0 |
|
|
|
|